Corbevax approved as heterologous vaccine for precaution dose: Centre
New Delhi, Aug 10 (IANS) The Centre on Wednesday approved Biological E’s Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin. In a letter to states, Union Health